Avivagen says ‘numerous’ parties interested in M&A talks with struggling firm
Troubled Ottawa-based life sciences firm Avivagen says it has received “numerous responses” from companies that are interested in potentially acquiring all or part of its
Avivagen says ‘numerous’ parties interested in M&A talks with struggling firm
Troubled Ottawa-based life sciences firm Avivagen says it has received “numerous responses” from companies that are interested in potentially acquiring all or part of its
Deals will see Ottawa-based company ship a total of about six tonnes of its immune-boosting compound to poultry, livestock and dairy producers in the three
Avivagen bets on OxC-beta to unlock global livestock supplement markets
An Ottawa life sciences firm has the green light to test the product in the world’s most populous country as it looks to reverse years
Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans
Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored